drugset / Trial / NCT00372827

Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension

NCT00372827

Phase 4 Completed 245 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to compare the efficacy and safety of Timolol 0.5% solution to Brinzolamide 1% each given twice daily when added to Travoprost 0.004% given each evening.

Timeline

Start
2004-02
Primary completion
2006-01
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Brinzolamide Small molecule 1 %
Background Travoprost Other / unclassified 0.004 %